Risk of Second Breast Cancers After Lobular Carcinoma in Situ According to Hormone Receptor Status

PLoS ONE - United States
doi 10.1371/journal.pone.0176417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Associations of Hormone-Related Factors With Breast Cancer Risk According to Hormone Receptor Status Among White and African American Women

Clinical Breast Cancer
Cancer ResearchOncology
2014English

Clonal Relationships Between Lobular Carcinoma in Situ and Other Breast Malignancies

Breast Cancer Research
Cancer ResearchOncology
2016English

Histopathological Grade Versus Hormone Receptor Status in Breast Carcinoma- Treasure the Past

International Journal of Biomedical Research
2015English

Breast Cancer Prevention Strategies in Lobular Carcinoma in Situ: A Decision Analysis

Cancer
Cancer ResearchOncology
2017English

Lobular Carcinoma in Situ (LCIS) of the Breast: Is Long-Term Outcome Similar to Ductal Carcinoma in Situ (DCIS)? Analysis of 200 Cases

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2015English

Clinical Significance and Prognostic Value of Receptor Conversion in Hormone Receptor Positive Breast Cancers After Neoadjuvant Chemotherapy

World Journal of Surgical Oncology
SurgeryOncology
2018English

Hormone Replacement Therapy Quadruples Risk of Breast Cancers

BMJ
2008English

Genetic Analysis of Lobular Carcinoma in Situ and Associated Invasive Lobular Cancer

Breast Cancer Research
Cancer ResearchOncology
2010English

Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy